Sg Americas Securities, LLC Protagonist Therapeutics, Inc Transaction History

Sg Americas Securities, LLC

$29.7 Billion
Q3 2025

A detailed history of Sg Americas Securities, LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 41,246 shares of PTGX stock, worth $3.49 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

41,246

Previous 1,924 2043.76%

Holding current value

$3.49 Million

Previous $106,000 2484.91%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	BUY	$49.7 - $67.42 $1.95 Million - $2.65 Million	39,322 Added 2043.76%	41,246 $2.74 Million
Q2 2025 Aug 08, 2025	BUY	$40.89 - $56.37 $78,672 - $108,455	1,924 New	1,924 $106,000
Q3 2024 Oct 03, 2024	BUY	$33.72 - $47.33 $498,685 - $699,963	14,789 Added 135.05%	25,740 $1.16 Million
Q2 2024 Jul 12, 2024	BUY	$24.66 - $34.8 $270,051 - $381,094	10,951 New	10,951 $379,000
Q2 2023 Jul 10, 2023	BUY	$18.02 - $29.36 $3.19 Million - $5.2 Million	177,241 Added 957.28%	195,756 $5.41 Million

Q1 2023 Apr 28, 2023	SELL	$10.78 - $25.38 $416,172 - $979,820	-38,606 Reduced 67.59%	18,515 $426,000
Q4 2022 Feb 02, 2023	SELL	$7.36 - $11.17 $317,061 - $481,192	-43,079 Reduced 42.99%	57,121 $623,000
Q3 2022 Oct 31, 2022	SELL	$7.86 - $11.71 $415,267 - $618,674	-52,833 Reduced 34.52%	100,200 $845,000
Q2 2022 Jul 29, 2022	BUY	$7.06 - $25.52 $847,722 - $3.06 Million	120,074 Added 364.31%	153,033 $1.21 Million
Q1 2022 Apr 29, 2022	SELL	$23.34 - $36.08 $130,493 - $201,723	-5,591 Reduced 14.5%	32,959 $780,000
Q4 2021 Feb 07, 2022	BUY	$17.63 - $37.1 $338,213 - $711,726	19,184 Added 99.06%	38,550 $1.32 Million
Q3 2021 Nov 01, 2021	BUY	$12.95 - $49.69 $214,400 - $822,667	16,556 Added 589.18%	19,366 $343,000
Q2 2021 Aug 12, 2021	SELL	$25.57 - $44.88 $151,246 - $265,465	-5,915 Reduced 67.79%	2,810 $126,000
Q1 2021 May 13, 2021	BUY	$19.02 - $31.15 $165,949 - $271,783	8,725 New	8,725 $226,000
Q4 2020 Feb 04, 2021	SELL	$18.49 - $25.13 $100,215 - $136,204	-5,420 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$15.19 - $22.4 $103,960 - $153,305	-6,844 Reduced 55.81%	5,420 $106,000
Q2 2020 Jul 20, 2020	BUY	$6.19 - $18.84 $75,914 - $231,053	12,264 New	12,264 $217,000

Others Institutions Holding PTGX

# of Institutions

294

Shares Held

66.9M

Call Options Held

139K

Put Options Held

40.7K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $4.15B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Protagonist Therapeutics, Inc Transaction History